Harriette Van Spall, MD MPH 🇨🇦 @hvanspall · 29 Aug 2026
Can we lower risk after MI by lowering LDL-C earlier? 🎙️ At #ESCCongress2026, Dr Harriette Van Spall speaks with Prof Gilles Montalescot about #AMUNDSEN, a trial evaluating evolocumab before PCI in STEMI and NSTEMI patients. A fascinating discussion on timing, prevention and https://t.co/ETkoib62g7
1 797Views
3Likes
1Reposts
0Replies
1Quotes
0Bookmarks
Is that a lot?
0.91×vs this author's median1 976 views is typical
25Percentile for this authorof 8 recent posts
0.47×vs 10K–100K median3 808 views is typical
9.72%Reachviews ÷ followers
0.28%Engagement rateof viewers reacted